FDA Approved: * May 14, 2021 Pharm Company: *ACTAVIS LABS FL INC Category:Cancer
Enzalutamide, sold under the brand name Xtandi, is a nonsteroidal antiandrogen (NSAA) medication which is used in the treatment of prostate cancer. It is indicated for use in conjunction with castration in the treatment of metastatic castration-resistant prostate cancer (mCRPC), nonmetastatic castration-resistant prostate cancer, and metastatic castration-sensitive prostate cancer (mCSPC). It is ta...
* May have multiple approval dates, manufacturers, or labelers. 1 Discussion